Skip to main content
OpenTrials
Completed

NCT Number: NCT00766792

Removal of Uremic Toxins With Nocturnal Dialysis Versus Standard Dialysis

Dialysis patients, who decide to switch from standard dialysis (3 times 240-270 min/week) to nocturnal dialysis (3 times 480 min/week), will be followed. In parallel a control group with patients staying on standard dialysis will be followed. The study will last 30 weeks. During this period blood samples (pre- and post-dialysis: 10 times; inlet and outlet of dialyzer: 3 times) will be collected on predetermined time points. Concentration of several uremic retention solutes will be determined.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age > 18 years

Exclusion criteria

  • pregnancy

Treatment and study plan

Nocturnal dialysis

Procedure

Switch to nocturnal dialysis (3 times 480 min/week)

Standard dialysis

Procedure

Standard dialysis (3 times 240-270 min/week)

Primary outcomes

  1. To evaluate what is more effective for removal of uremic toxins - nocturnal versus standard dialysis?

    Time frame: 30 weeks

Sponsors and collaborators

Lead sponsor

University Hospital, Ghent

Other

Registry information

Important dates

Study start
2005
Primary completion
2008
Study completion
2008
First posted
Oct 6, 2008
Registry last updated
Oct 31, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.